A proposed phasing-out of race-day Lasix starting in 2020 that is being discussed by track operators in Kentucky and New York has yet to formally involve representatives from the Horsemen’s Benevolent and Protective Association (HBPA), Eric Hamelback, the group’s national chief executive, told TDN Wednesday afternoon.
“The groups that own racetracks have every right to discuss safety measures for the industry. Any kind of discussions for safety are positive discussions,” Hamelback said. “But there were no direct discussions with the HBPA about this as a proposal. I checked with the Kentucky HBPA, and there wasn’t even a formal discussion. The overall feeling–mine and theirs–is we certainly need to listen to what any track wants to propose as a safety measure.”